Pro-Lab Diagnostics, founded in 1974, stands as a robust player in the Biotechnology and Health Care sectors, with a strategic base in Canada and operational footprints in the United Kingdom and the United States.
The company's slogan, "Deliver today and research for tomorrow," encapsulates its dual focus on immediate product availability and ongoing innovation. Pro-Lab has earned rigorous certifications, being registered under ISO 13585:2003 (CMDCAS) and recognized by both the Therapeutic Products Directorate (TPD) of Health Canada and the Food and Drug Administration (FDA) of the United States.
The firm's expertise in manufacturing high-quality, cost-effective immunodiagnostic reagents and its extensive distribution network of innovative products caters to various medical and scientific disciplines. Noteworthy is their specialization in OEM (private label) packaging. Despite its longstanding market presence, Pro-Lab has not disclosed any recent investments, indicating potential opportunities for new investors in this established yet forward-thinking company.